☰

Mark Norman Levine, MSc, MD - Publications

Affiliations: 
Oncology McMaster University, Hamilton, ON, Canada 
Website:
https://experts.mcmaster.ca/display/mlevine
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901461. PMID 31381464 DOI: 10.1200/JCO.19.01461  0.36
2018 Nauman G, Gray JC, Parkinson R, Levine M, Paller CJ. Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials. Antioxidants (Basel, Switzerland). 7. PMID 30002308 DOI: 10.3390/Antiox7070089  0.329
2018 Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, Hale D, Dunn JA, Lyman GH, Hutchinson C, MacCallum P, Kakkar A, Hobbs FDR, Petrou S, Dale J, ... ... Levine M, et al. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018788034. PMID 29746227 DOI: 10.1200/JCO.2018.78.8034  0.323
2017 Polireddy K, Dong R, Reed G, Yu J, Chen P, Williamson S, Violet PC, Pessetto Z, Godwin AK, Fan F, Levine M, Drisko JA, Chen Q. High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study. Scientific Reports. 7: 17188. PMID 29215048 DOI: 10.1038/s41598-017-17568-8  0.324
2016 Schünemann HJ, Ventresca M, Crowther M, Briel M, Zhou Q, Garcia D, Lyman G, Noble S, Macbeth F, Griffiths G, DiNisio M, Iorio A, Beyene J, Mbuagbaw L, Neumann I, ... ... Levine M, et al. Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. Bmj Open. 6: e010569. PMID 27130164 DOI: 10.1136/Bmjopen-2015-010569  0.529
2015 Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 654-6. PMID 25605844 DOI: 10.1200/JCO.2014.59.7351  0.333
2014 Levine MN, Parpia S, Julian J. Treating clots in cancer: moving closer to an answer? The Lancet. Haematology. 1: e6-7. PMID 27030068 DOI: 10.1016/S2352-3026(14)70020-1  0.309
2014 Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Science Translational Medicine. 6: 222ra18. PMID 24500406 DOI: 10.1126/scitranslmed.3007154  0.325
2013 Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2189-204. PMID 23669224 DOI: 10.1200/JCO.2013.49.1118  0.358
2012 Elit LM, Lee AY, Parpia S, Swystun LL, Liaw PC, Hoskins P, Julian DH, Julian JA, Levine MN. Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study. Thrombosis Research. 130: 894-900. PMID 23046525 DOI: 10.1016/j.thromres.2012.09.010  0.346
2012 Douketis JD, Ginsberg JS, Haley S, Julian J, Dwyer M, Levine M, Eisenberg PR, Smart R, Tsui W, White RH, Morris TA, Kaatz S, Comp PC, Crowther MA, Kearon C, et al. Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. Thrombosis Research. 130: 381-9. PMID 22658414 DOI: 10.1016/j.thromres.2012.05.011  0.355
2011 Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, Joy AA, Provencher L, Rayson D, Rheaume DE, Porter GA, Paszat LF, Pritchard KI, Robidoux A, Smith S, ... ... Levine MN, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4755-62. PMID 22042959 DOI: 10.1200/JCO.2011.36.8373  0.31
2009 Evans WK, Laupacis A, Gulenchyn KY, Levin L, Levine M. Evidence-based approach to the introduction of positron emission tomography in ontario, Canada. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5607-13. PMID 19858395 DOI: 10.1200/Jco.2009.22.1614  0.339
2009 Rana P, Levine MN. Prevention of thrombosis in ambulatory patients with cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4885-8. PMID 19752331 DOI: 10.1200/JCO.2009.23.5481  0.413
2009 Levine MN. New antithrombotic drugs: potential for use in oncology. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4912-8. PMID 19738103 DOI: 10.1200/JCO.2009.24.7346  0.399
2008 Dayes IS, Levine MN, Julian JA, Pritchard KI, D'Souza DP, Kligman L, Reise D, Wiernikowski JA, Bonilla L, Whelan TJ. Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial. Breast Cancer Research and Treatment. 110: 337-42. PMID 17851756 DOI: 10.1007/s10549-007-9727-0  0.302
2007 Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5490-505. PMID 17968019 DOI: 10.1200/Jco.2007.14.1283  0.573
2006 Lee A, Levine M. Treatment of venous thromboembolism in cancer patients. Cancer Control : Journal of the Moffitt Cancer Center. 17-21. PMID 16179900 DOI: 10.1177/1073274805012003S04  0.361
2006 Levine M. Home-treatment of deep vein thrombosis in patients with cancer. Haematologica. 90: 150. PMID 15713578  0.348
2005 Parulekar WR, Day AG, Ottaway JA, Shepherd LE, Trudeau ME, Bramwell V, Levine M, Pritchard KI. Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6002-8. PMID 16135468 DOI: 10.1200/JCO.2005.07.096  0.34
2005 Kovacs MJ, Levine MN, Keeney M, Mackinnon KM, Lee AY. Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients. Thrombosis and Haemostasis. 93: 1185-8. PMID 15968406 DOI: 10.1160/TH05-01-0052  0.403
2005 Lee AY, Rickles FR, Julian JA, Gent M, Baker RI, Bowden C, Kakkar AK, Prins M, Levine MN. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2123-9. PMID 15699480 DOI: 10.1200/JCO.2005.03.133  0.607
2004 Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 126: 287S-310S. PMID 15383476 DOI: 10.1378/Chest.126.3_Suppl.287S  0.469
2004 Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, Rustin G, Thomas M, Quigley M, Williamson RC. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1944-8. PMID 15143088 DOI: 10.1200/JCO.2004.10.002  0.432
2004 Levine M. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients. Seminars in Thrombosis and Hemostasis. 9-11. PMID 14730472 DOI: 10.1055/S-2003-45410  0.432
2003 Schafer AI, Levine MN, Konkle BA, Kearon C. Thrombotic disorders: diagnosis and treatment. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 520-39. PMID 14633797  0.321
2003 Levine MN, Lee AY. Risk assessment and primary VTE prevention in the cancer patient. Pathophysiology of Haemostasis and Thrombosis. 33: 36-41. PMID 12954999  0.336
2003 Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE Survey Oncologist. 8: 381-388. PMID 12897335 DOI: 10.1634/Theoncologist.8-4-381  0.385
2003 Levine MN. Can we optimise treatment of thrombosis? Cancer Treatment Reviews. 29: 19-22. PMID 12887946 DOI: 10.1016/S0305-7372(03)80005-1  0.474
2003 Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. The New England Journal of Medicine. 349: 146-53. PMID 12853587 DOI: 10.1056/NEJMoa025313  0.624
2003 Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation. 107: I17-21. PMID 12814981 DOI: 10.1161/01.CIR.0000078466.72504.AC  0.459
2002 Levine MN. Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer. Cancer Treatment Reviews. 28: 145-9. PMID 12234566 DOI: 10.1016/S0305-7372(02)00042-7  0.404
Show low-probability matches.